Načítá se...

Two Cases of Atezolizumab-Induced Hypophysitis

Cancer immunotherapy has emerged as treatment of multiple advanced cancer types. Immune checkpoint inhibitors, namely anticytotoxic T-lymphocyte antigen-4 (CTLA-4), antiprogrammed cell death-1 (PD-1), and antiprogrammed cell death-1 ligand 1 (PD-L1) antibodies, have been used for treatment of variou...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Endocr Soc
Hlavní autoři: Kanie, Keitaro, Iguchi, Genzo, Bando, Hironori, Fujita, Yasunori, Odake, Yukiko, Yoshida, Kenichi, Matsumoto, Ryusaku, Fukuoka, Hidenori, Ogawa, Wataru, Takahashi, Yutaka
Médium: Artigo
Jazyk:Inglês
Vydáno: Endocrine Society 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5774896/
https://ncbi.nlm.nih.gov/pubmed/29362727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2017-00414
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!